Newsletters

Psychiatry Advisor

• Online Therapy vs In-Person Therapy: The Physician’s Perspective May 3, 2024
  Since the onset of the COVID-19 pandemic, the use of online therapy has greatly increased, expanding the availability of mental health services for individuals for whom in-person therapy is not available, affordable, or convenient. The post Online Therapy vs In-Person Therapy: The Physician’s Perspective appeared first on Psychiatry Advisor.
  Claudia
• Therapist Burnout Negatively Affects Patient Outcomes During Psychotherapy May 3, 2024
  Researchers used data from the US Veterans Affairs Health Care System to evaluate the effect of therapist burnout on patient outcomes following psychotherapy for PTSD. The post Therapist Burnout Negatively Affects Patient Outcomes During Psychotherapy appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• No Evidence of Dementia, Brain Atrophy With Antidepressant Use May 3, 2024
  Investigators used data from the Rotterdam Study to evaluate the association between antidepressant use and cognition, brain atrophy, and dementia risk. The post No Evidence of Dementia, Brain Atrophy With Antidepressant Use appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Pandemic Had Modest Effect on Early Childhood Development Milestones May 3, 2024
  Modest changes were seen in early childhood development milestone achievement during the COVID-19 pandemic. The post Pandemic Had Modest Effect on Early Childhood Development Milestones appeared first on Psychiatry Advisor.
  Haymarket Media
• Long-Term Smell, but Not Taste, Deficits Seen After COVID-19 May 3, 2024
  Olfactory dysfunction, especially for smell, is more common in individuals with prior COVID-19 vs individuals with no history of infection. The post Long-Term Smell, but Not Taste, Deficits Seen After COVID-19 appeared first on Psychiatry Advisor.
  Haymarket Media
• Updated 2023-2024 COVID-19 Vaccine Recommended for Immunocompromised Adults May 3, 2024
  Researchers evaluated vaccine effectiveness of the updated 2023-2024 COVID-19 vaccine among immunocompromised adults. The post Updated 2023-2024 COVID-19 Vaccine Recommended for Immunocompromised Adults appeared first on Psychiatry Advisor.
  Aleta Terrill
• COVID-19 Vaccine 2023-2024 Formulation: Effectiveness Lower Than Expected May 3, 2024
  Researchers evaluated the effectiveness of the 2023-2024 formulation of the mRNA COVID-19 vaccine among employees at a health system in Cleveland, Ohio. The post COVID-19 Vaccine 2023-2024 Formulation: Effectiveness Lower Than Expected appeared first on Psychiatry Advisor.
  Aleta Terrill
• Atogepant Safe, Well Tolerated for Prevention of Episodic Migraine May 3, 2024
  In a post hoc analysis of pooled data from 4 phase 3 RCTs and open-label clinical trials, researchers evaluated the overall safety and tolerability of atogepant for treatment of adults with episodic migraine. The post Atogepant Safe, Well Tolerated for Prevention of Episodic Migraine appeared first on Psychiatry Advisor.
  melissaalvarez
• High Scores for Adverse Childhood Experiences Linked to Chronic Pain in LGBTQ+ Adults May 3, 2024
  To address chronic pain effectively in those who identify as LGBTQ+, researchers sought to understand the link between childhood adversity and chronic pain, especially in the transgender and gender-diverse individuals. The post High Scores for Adverse Childhood Experiences Linked to Chronic Pain in LGBTQ+ Adults appeared first on Psychiatry Advisor.
  melissaalvarez
• Inhibition in ADHD: Girls Are Slow to Respond, Boys Have Poor Cognitive Control May 2, 2024
  Researchers conducted a study to evaluate performance metrics of cognitive control across multiple tasks in both boys and girls with ADHD. The post Inhibition in ADHD: Girls Are Slow to Respond, Boys Have Poor Cognitive Control appeared first on Psychiatry Advisor.
  Meahjabeen Hoque